Patients with Continuing Convulsive Seizures – A Third Generation AED Review

Selectively targeting mechanisms thought to be critical to seizure occurrence may expand therapeutic options for refractory epilepsy. This 30-minute program features a summary of key efficacy and safety data of the three third generation AEDs currently registered for use in Australia, clearly differentiating their respective indications for genetic generalised epilepsy and/or focal epilepsy. With a comprehensive case study that focusses on the importance of accurate seizure classification, adjunctive treatment selection and dosing to manage adverse effects, this program also offers expert video commentary from Professor Sam Berkovic to help you optimise your practice.